Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.

Anti-Bacterial Agents / therapeutic use Bacteremia / drug therapy Drug Resistance, Multiple, Bacterial Female Humans Male Microbial Sensitivity Tests Middle Aged Models, Biological Neoplasms / complications Neutropenia / complications Pseudomonas Infections / drug therapy Pseudomonas aeruginosa / drug effects ROC Curve Retrospective Studies Risk Factors Treatment Outcome
Pseudomonas aeruginosa bacteremia bloodstream infection cancer multidrug resistant neutropenia predictive model risk factors

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 14 12 2019
accepted: 25 01 2020
pubmed: 6 2 2020
medline: 23 2 2021
entrez: 5 2 2020
Statut: epublish

Résumé

We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR)

Identifiants

DOI: 10.1128/AAC.02494-19 PMID: 32015035 PMC: PMC7179320
pubmed: 32015035
pii: AAC.02494-19
doi: 10.1128/AAC.02494-19
pmc: PMC7179320
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Guillermo Cuervo (G)
Francesc Escrihuela-Vidal (F)
Fe Tubau (F)
Cristian Tebé (C)
Marisol Rodríguez Arias (M)
Juan Aguilar-Company (J)
Nieves Larrosa (N)
Celia Cardozo (C)
Carolina Garcia-Vidal (C)
Ibrahim Karim-Yaqub (I)
Raffaella Greco (R)
Paola Cichero (P)
Caglayan Merve Ayaz (CM)
Roberto Céspedes (R)
Leire López-Soria (L)
Laura Magnasco (L)
Jesús Fortún (J)
Diego Torres (D)
Anna Boté (A)
Mateu Espasa (M)
Mia Hold Montaguti (M)
Pierre-Yves Bochud (PY)
Oriol Manuel (O)
Salvador Tabares Carrasco (S)
Josefina Serrano López (J)
Hartmut Bertz (H)
Siegbert Rieg (S)
Marina de Cueto (M)
Jesús Rodríguez-Baño (J)
Manuel Lizasoain (M)
José María Aguado (JM)
Juan Pablo Horcajada (JP)
Saeed El Zein (S)
Jean-Francois Jabbour (JF)
Ayse Uyan-Onal (A)
Arzu Nazli-Zeka (A)
Begoña Palop (B)
Lina Clemencia Correa (LC)
Amanda Aparecida da Silva Machado (AADS)
João Pedro Silva Tonhá (JPS)
Georg Maschmeyer (G)
Jose Munita (J)
Matteo Bassetti (M)
Nadia Castaldo (N)
Paloma Sangro Del Alcázar (PS)

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Lancet Haematol. 2017 Dec;4(12):e573-e583
pubmed: 29153975
Antimicrob Agents Chemother. 2013 May;57(5):2326-32
pubmed: 23478961
Clin Infect Dis. 2017 Nov 13;65(11):1819-1828
pubmed: 29020364
Clin Infect Dis. 1997 Aug;25(2):247-59
pubmed: 9332520
PLoS One. 2018 Jun 28;13(6):e0199531
pubmed: 29953464
Haematologica. 2011 Jan;96(1):e1-3; author reply e4
pubmed: 21193424
J Infect. 2009 Apr;58(4):299-307
pubmed: 19272650
BMC Med Res Methodol. 2014 Mar 19;14:40
pubmed: 24645774
J Clin Oncol. 2000 Aug;18(16):3038-51
pubmed: 10944139
Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S240-5
pubmed: 15768329
Clin Microbiol Infect. 2020 Mar;26(3):345-350
pubmed: 31295551
Support Care Cancer. 1997 Jul;5(4):330-3
pubmed: 9257432
Transpl Infect Dis. 2019 Dec;21(6):e13186
pubmed: 31574202
Ann Hematol. 2012 Aug;91(8):1299-304
pubmed: 22349723
Clin Infect Dis. 2018 Nov 13;67(11):1720-1728
pubmed: 29701766
Clin Microbiol Infect. 2018 Jul;24(7):678-679
pubmed: 29549060
Clin Infect Dis. 2014 Jul 15;59(2):206-15
pubmed: 24729496
Diagn Microbiol Infect Dis. 2017 Aug;88(4):335-341
pubmed: 28529091
J Antimicrob Chemother. 2011 Mar;66(3):657-63
pubmed: 21193475
Clin Infect Dis. 2019 May 30;68(12):2045-2052
pubmed: 30256922
BMJ Open. 2019 May 24;9(5):e025744
pubmed: 31129580
Haematologica. 2013 Aug;98(8):1282-90
pubmed: 23508009
Haematologica. 2010 Sep;95(9):1612-5
pubmed: 20305140
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
BMC Med Res Methodol. 2007 Jul 13;7:33
pubmed: 17629912
Infection. 2014 Aug;42(4):721-8
pubmed: 24912861
J Infect. 2014 Apr;68(4):321-31
pubmed: 24370562
Clin Microbiol Infect. 2015 Apr;21(4):337-43
pubmed: 25595706
Virulence. 2016 Apr 2;7(3):280-97
pubmed: 27002635
BMC Infect Dis. 2017 Jul 17;17(1):500
pubmed: 28716109
Clin Microbiol Infect. 2013 May;19(5):474-9
pubmed: 22524597
J Infect. 2016 Oct;73(4):336-45
pubmed: 27404978
Diagn Progn Res. 2018 Jun 12;2:11
pubmed: 31093561

Auteurs

C Gudiol (C)

Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain cgudiol@iconcologia.net jcarratala@bellvitgehospital.cat.
Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
ORCID: 0000-0003-3095-4422

A Albasanz-Puig (A)

Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

J Laporte-Amargós (J)

Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.

N Pallarès (N)

Statistics Advisory Service, Institute of Biomedical Research of Bellvitge, Barcelona, Spain.

A Mussetti (A)

Haematology Department, Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.

I Ruiz-Camps (I)

Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

P Puerta-Alcalde (P)

Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

E Abdala (E)

Instituto do Câncer do Estado de São Paulo, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

C Oltolini (C)

Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

M Akova (M)

Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.

M Montejo (M)

Infectious Diseases Unit, Cruces University Hospital, Bilbao, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

M Mikulska (M)

Division of Infectious Diseases, University of Genoa (DISSAL) and Ospedale Policlinico San Martino, Genoa, Italy.

P Martín-Dávila (P)

Infectious Diseases Department, Ramon y Cajal Hospital, Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

F Herrera (F)

Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.

O Gasch (O)

Infectious Diseases Department, Parc Taulí University Hospital, Sabadell, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

L Drgona (L)

Oncohematology Department, Comenius University and National Cancer Institute, Bratislava, Slovakia.

H Paz Morales (H)

Infectious Diseases Department, Hospital Erasto Gaertner, Curitiba, Brazil.

A-S Brunel (AS)

Infectious Diseases Department, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

E García (E)

Haematology Department, Reina Sofía University Hospital-IMIBIC-UCO, Córdoba, Spain.

B Isler (B)

Department of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital, Istanbul, Turkey.

W V Kern (WV)

Division of Infectious Diseases, Department of Medicine II, University of Freiburg Medical Center and Faculty of Medicine, Freiburg, Germany.

I Morales (I)

Emergency Clinical Unit and Infectious Diseases Division, Hospital Universitario Virgen Macarena, Seville, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

G Maestro-de la Calle (G)

Infectious Diseases Unit, Instituto de Investigación Hospital 12 de Octubre (i+12), 12 de Octubre University Hospital, School of Medicine, Universidad Complutense, Madrid, Spain.

M Montero (M)

Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigations Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

S S Kanj (SS)

Infectious Diseases Division, American University of Beirut Medical Center, Beirut, Lebanon.

O R Sipahi (OR)

Ege University Faculty of Medicine, Izmir, Turkey.

S Calik (S)

University of Health Science Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.

I Márquez-Gómez (I)

Infectious Diseases Department, Hospital Regional de Málaga, Málaga, Spain.

J I Marin (JI)

Infectious Diseases and Clinical Microbiology Department, Clínica Maraya, Pereira, Colombia.
Critical Care and Clinical Microbiology Department, Manizales, Colombia.

M Z R Gomes (MZR)

Hospital Federal dos Servidores do Estado and Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Ministério da Saúde, Rio de Janeiro, Brazil.
ORCID: 0000-0001-6492-1034

P Hemmatti (P)

Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of Charité University Medical School, Berlin, Germany.

R Araos (R)

Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile.
Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago de Chile, Chile.

M Peghin (M)

Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Udine, Italy.

J L Del Pozo (JL)

Infectious Diseases and Microbiology Unit, Navarra University Clinic, Pamplona, Spain.

L Yáñez (L)

Haematology Department, Marqués de Valdecilla University Hospital, Santander, Spain.

R Tilley (R)

Microbiology Department, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

A Manzur (A)

Infectious Diseases, Hospital Rawson, San Juan, Argentina.

A Novo (A)

Haematology Department, Son Espases University Hospital, Palma de Mallorca, Spain.

J Carratalà (J)

Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain cgudiol@iconcologia.net jcarratala@bellvitgehospital.cat.
Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Bactériémie › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Tumeurs › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Troubles leucocytaires › Leucopénie › Agranulocytose › Neutropénie › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Pseudomonas › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Courbe ROC › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Clinical Predictive Model of Multidrug...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Clinical Predictive Model of Multidrug...